Sign in Subscribe

liquid-biopsy

A collection of 10 issues

Baseline ctDNA profiling informs HER2-targeted therapy outcomes

Skip to content The CRC Digest Baseline ctDNA profiling informs HER2-targeted therapy outcomes TRIUMPH/MyPathway analysis shows baseline circulating tumor DNA and prior anti-EGFR therapy affect pertuzumab plus trastuzumab efficacy in HER2-amplified metastatic colorectal cancer. (ESMO Open) This content is informational only and does not constitute medical advice. Always consult

ctDNA clearance as early biomarker in KRAS G12C colorectal cancer

Skip to content The CRC Digest ctDNA clearance as early biomarker in KRAS G12C colorectal cancer Phase 3 CodeBreaK 300 results link circulating tumor DNA clearance to efficacy and prognosis with sotorasib plus panitumumab. (JCO) This content is informational only and does not constitute medical advice. Always consult your oncologist

Practical guidance for integrating ctDNA testing into clinical care

Skip to content The CRC Digest Practical guidance for integrating ctDNA testing into clinical care A narrative review summarizes evidence for ctDNA minimal residual disease testing in gastrointestinal cancers, with strongest data supporting use in resected stage II colon cancer. (Clinical and Translational Oncology) This content is informational only and

Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence

Skip to content The CRC Digest Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence A review of current evidence suggests circulating tumor DNA has significant prognostic and predictive potential for detecting minimal residual disease and individualizing adjuvant therapy in colorectal cancer. (Klinická Onkologie) This content is informational only

Blood-Based ctDNA Testing May Help Monitor for Cancer Return After Surgery

Skip to content The CRC Digest Blood-Based ctDNA Testing May Help Monitor for Cancer Return After Surgery Meta-analysis supports use of circulating tumor DNA as a biomarker to detect recurrence risk in patients who had liver metastases surgically removed. (Clinical Colorectal Cancer) This content is informational only and does not

Blood-Based Screening Biomarkers Under Review

Skip to content The CRC Digest Blood-Based Screening Biomarkers Under Review Researchers identified novel blood test candidates that could complement or enhance current colorectal cancer screening approaches. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The

ctDNA Among Novel Screening Biomarkers

Skip to content The CRC Digest ctDNA Among Novel Screening Biomarkers Systematic review highlights circulating tumor DNA as a candidate for blood-based colorectal cancer screening. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest

CRC Research Finding

Skip to content The CRC Digest ▪ Review Identifies Promising Blood-Based Biomarkers for CRC Screening A systematic review examined novel blood tests, including circulating tumor DNA (ctDNA), that could help detect colorectal cancer and precancerous conditions earlier through less invasive screening methods. (Clinical Colorectal Cancer) This content is informational only and

ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery

Skip to content The CRC Digest ctDNA testing offers noninvasive approach to detect minimal residual disease after surgery Scoping review examines how circulating tumor DNA can guide adjuvant therapy decisions and surveillance strategies in resected CRC. (Journal of Gastrointestinal Surgery) This content is informational only and does not constitute medical

Fecal hemoglobin testing linked to improved colorectal cancer survival

Skip to content The CRC Digest Fecal hemoglobin testing linked to improved colorectal cancer survival Research suggests that fecal hemoglobin screening may contribute to better survival outcomes in colorectal cancer patients. (Bioengineer.org) This content is informational only and does not constitute medical advice. Always consult your oncologist or care